SEC Company Response from Stealth BioTherapeutics Corp (CIK 0001696396) — Jun 13, 2022
Stealth BioTherapeutics Corp (CIK 0001696396)
Date: June 13, 2022 · CIK: 0001696396 · Accession: 0001564590-22-023057
AI Filing Summary & Sentiment
File numbers found in text: 333-265423
Show Raw Text
CORRESP 1 filename1.htm mito-corresp.htm STEALTH BIOTHERAPEUTICS CORP c/o Intertrust Corporate Services (Cayman) Limited One Nexus Way Camana Bay, Grand Cayman KY1-9005 Cayman Islands June 13, 2022 VIA EDGAR SUBMISSION Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Stealth BioTherapeutics Corp Registration Statement on Form F-1 File No. 333-265423 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Stealth BioTherapeutics Corp hereby requests acceleration of the effective date of its Registration Statement on Form F-1 (File No. 333-265423), so that it may become effective at 4:00 p.m., Eastern time, on June 15, 2022, or as soon as practicable thereafter. Very truly yours, STEALTH BIOTHERAPEUTICS CORP By: /s/ Irene P. McCarthy Name: Title: Irene P. McCarthy Chief Executive Officer